WT
|
-
|
79%
|
68%
| |
CTF8
|
CHTF8
|
49%
|
-
|
-
|
MSH2
|
MSH2
|
56%
|
-
|
RNAi-mediated knockdown decreases apoptosis [25]
|
MUS81
|
MUS81
|
56%
|
-
|
-
|
TPD3
|
PPP2R1B
|
60%
|
-
|
RNAi-mediated knockdown decreases apoptosis [26]
|
TOP1
|
TOP1
|
55%
|
-
|
RNAi-mediated knockdown reduces nuclear apoptosis [27]
|
RAD54
|
RAD54L
|
44%
| |
-
|
SMC3
|
SMC3
|
-
|
30%
|
RNAi-mediated knockdown increases apoptosis [28]
|
RAD1
|
ERCC4
|
-
|
22%
|
-
|
DNL4
|
LIG4
|
-
|
46%
|
Extensive apoptosis in mouse deletion homozygotes [29]
|
MAD1
|
MAD1L1
|
-
|
20%
|
-
|
MEU1
|
MTAP
|
-
|
94%
|
Pharmacological targeting of MTAP promotes apoptosis [30]
|
MLH1
|
MLH1
|
-
|
93%
|
Abnormal apoptosis (OMIM)
|
CHK1
|
CHEK1
|
-
|
82%
|
Blocking CHK1 induces apoptosis [31]
|
UBX4
|
ASPSCR1
|
-
|
80%
|
Regulator of apoptosis (OMIM)
|